The latest price target for CareMax (NASDAQ:CMAX) was reported by UBS on April 1, 2024. The analyst firm set a price target for $6.40 expecting CMAX to rise to within 12 months (a possible 771.93% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for CareMax (NASDAQ:CMAX) was provided by UBS, and CareMax maintained their neutral rating.

There is no last upgrade for CareMax

The last downgrade for CareMax Inc happened on November 17, 2023 when UBS changed their price target from $5 to $1 for CareMax Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareMax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareMax was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.

While ratings are subjective and will change, the latest CareMax (CMAX) rating was a maintained with a price target of $7.00 to $6.40. The current price CareMax (CMAX) is trading at is $0.73, which is out of the analyst’s predicted range.